Weekly Paclitaxel for Recurrent Ovarian Cancer: Does Weekly Administration at Primary Diagnosis Impact Efficacy and Toxicity at Recurrence?
AuthID
P-00V-T9G
P-00V-T9G
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service